Medicine security – a national UK priority.
Concerns about medicines shortages in the UK have been highlighted in recent analysis from the House of Lords Public Services Committee and the Royal Pharmaceutical Society.
The House of Lords Public Services Committee warns that medicines supply should be treated as a national resilience issue, noting the UK’s heavy reliance on complex global supply chains and overseas manufacturing. It argues that the current approach is too reactive and calls for stronger national leadership, better data sharing and clearer oversight of shortages.
The Royal Pharmaceutical Society also emphasises the growing impact on patients and pharmacy teams. Even when only a small proportion of medicines are affected, shortages can lead to treatment delays, additional workload for healthcare professionals and anxiety for patients.
Both organisations stress the need for coordinated action to strengthen supply chains and ensure reliable access to medicines.
Read the full articles here:
Lords Committee calls for proactive leadership to tackle medicines supply
Royal Pharmaceutical Society – Medicines Shortages: Solutions for empty shelves
(Summary and title image generated with AI)
Recent Blog Posts
Patient Survey: Improving the Delivery of Genetic Results
CAH is a rare genetic condition and many of us will have received results of genetic testing at some point on our CAH journey. When you received these reults might not have been at the best time - pehaps you received genomic test results while you were driving, on...
Webinar: Finding Your Way – A Parent’s Guide to Rare Disease
Join the NHS South East Genomic Medicine Service and Unique on Wednesday 16th September 2026 at 12-1pm on Teams to celebrate the launch of “Finding Your Way: A Parent's Guide to Rare Disease”. Written by parents, for parents, this new guide offers practical support,...
New report highlights access gap for innovative medicines
The CAH Support Group recently provided input into a new Medicines Australia report about access to innovative medicines in Australia. The report, now published, warns that Australian patients are missing access to some innovative medicines available in comparable...